WilliamHillÖÐÎĹٷ½ÍøÕ¾

xinwenbanpc1.jpg c1panph.jpg

R&D Innovation

Steering us through complexity and competitiveness

Research & Development Innovation

Innovation is in GenSci's DNA. GenSci advances a robust, innovative portfolio across four therapeutic areas: endocrinology & metabolism, women's health, immunology & respiratory diseases, and oncology.


Guided by global R&D strategy, besides robust research engines, we execute Multi-Regional Clinical Trials (MRCT) with high efficiency and high standards in China and overseas. Our innovation engine is powered by cutting-edge technology platforms, enhanced by AI to enable precision-targeting therapeutic development. 


Concurrently, we are building a global R&D network to foster worldwide collaboration. This network is crucial for accelerating our research and development of innovative medicines and ensures our research outcomes finely calibrated to address the complex and diverse needs of global markets.




686394.jpg
  • 35+

    Clinical Pipeline

  • 8

    Multi-Regional Clinical Trials

  • 22%

    R&D investment as a percentage of sales revenue in 2024

  • 90+

    Held Patents £»£»£»£»£»£»£»£»
    Pending Applications: 279 £»£»£»£»£»£»£»£»
    International Patents Submitted: 56

ratio.png

ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø

R&D Highlight

We leverage cutting-edge technologies to accelerate drug discovery and build differentiated pipelines targeting major diseases.

  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi05.jpg
    AI-Empowered

    Leverage AI to speed drug discovery and development

    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi05.jpg
    AI-EmpoweredLeverage AI to speed drug discovery and development
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi01.jpg
    Top Technology

    Develop differentiated and leading platforms

    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi01.jpg
    Top TechnologyDevelop differentiated and leading platforms
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi02.jpg
    Unmet Needs

    Focus on therapeutic areas with clinical unmet needs

    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi02.jpg
    Unmet NeedsFocus on therapeutic areas with clinical unmet needs
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi03.jpg
    Large Investment

    Invest significantly in R&D

    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi03.jpg
    Large InvestmentInvest significantly in R&D
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi04.jpg
    Global Cooperation

    Team up with innovators worldwide

    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø guanwangyanfatixi04.jpg
    Global CooperationTeam up with innovators worldwide
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
    ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø

R&D Centers

Five major R&D centers power unceasing innovation

  • Shanghai R&D Center

  • Changchun R&D Center

  • Beijing R&D Center

  • U.S. R&D Center

  • European R&D Center

  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø tupian1.png
    Shanghai R&D Center

    Equipped to house 2,000 R&D professionals, this state-of-the-art facility leads in translational medicine and clinical research. It is at the forefront of discovering new drug targets and forging strategic alliances to convert innovative ideas into practical medical solutions.


  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø a.jpg
    Changchun R&D Center

    Serves as a vibrant hub of innovation and a nucleus for the industrialization of biopharmaceuticals and chemical medicines, deftly guiding the product development lifecycle from inception to successful market entry.


  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø beijingyanfazhongxin.jpg
    Beijing R&D Center

    Actively conducts essential medical research and rigorously oversees the new product registration process to meet exacting regulatory standards, critical for our strategic market expansion and product diversification within China.


  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø c1meiguoyanfazhongxin1.jpg
    U.S. R&D Center

    Located in Washington D.C., the center is positioned as a strategic nexus for market expansion and R&D tailored to the U.S. market.  This center is crucial for aligning our R&D endeavors with the needs of a major pharmaceutical market, thereby enhancing our global competitiveness.

  • ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø c1ouzhouyanfazhongxin1.jpg
    European R&D Center

    Located in Lausanne, Switzerland, this center is pivotal to our strategic expansion across Europe, crafting R&D strategies that are in perfect harmony with European regulatory standards. It plays an essential role in keeping our products at the cutting edge of competitiveness and compliance within the European pharmaceutical market.


ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
ÍþÁ®Ï£¶û¡¤williamhill(Öйú)ÖÐÎĹÙÍø
ÍøÕ¾µØÍ¼